Amgen Announces Webcast of 2008 Fourth Quarter and Full Year Financial Results
THOUSAND OAKS, Calif., Jan. 20 /PRNewswire-FirstCall/ -- Amgen (Nasdaq:
AMGN) today announced that it plans to report its fourth quarter and full year
financial results on Monday, Jan. 26, 2009 after the close of the financial
markets. The announcement will be followed by a conference call with the
investment community at 2:00 p.m. Pacific Time. Participating in the call
from Amgen will be Kevin Sharer, chairman and chief executive officer, and
other members of Amgen's senior management team.
Live audio of the conference call will be simultaneously broadcast over
the Internet and will be available to members of the news media, investors and
the general public. The conference call, including the question and answer
session, is expected to last approximately one hour.
The webcast of the conference, as with other selected presentations
regarding developments in Amgen's business given by management at certain
investor and medical conferences, can be found on Amgen's Web site,
www.amgen.com, under Investors. Information regarding presentation times,
webcast availability, and webcast links are noted on Amgen's Investor
Relations Events Calendar. The webcast will be archived and available for
replay 72 hours after the event.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative human
therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first
companies to realize the new science's promise by bringing safe and effective
medicines from lab, to manufacturing plant, to patient. Amgen therapeutics
have changed the practice of medicine, helping millions of people around the
world in the fight against cancer, kidney disease, rheumatoid arthritis, and
other serious illnesses. With a deep and broad pipeline of potential new
medicines, Amgen remains committed to advancing science to dramatically
improve people's lives. To learn more about our pioneering science and our
vital medicines, visit www.amgen.com.
CONTACT: Amgen, Thousand Oaks
David Polk, 805-447-4613 (media)
Arvind Sood, 805-447-1060 (investors)
(Logo: http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO)
SOURCE Amgen
